Life Sciences is pumping up its flow cytometry portfolio with the addition of 14 new human monoclonal antibodies from Trillium Diagnostics LLC. The analyte-specific reagents (ASRs) provide high specificity, convenience, and flexibility in flow cytometry. A new cell permeabilization reagent is also being offered.
The new monoclonals include human anti-hemoglobin F, which recognizes fetal hemoglobin molecules; CD163 markers for anti-inflammatory signal and disease research; and CD64 markers, which react with Fc gamma 1 receptors.
Rounding out the line is a monoclonal for MNDA (myeloid nuclear differentiation antigen). All antibodies are available unconjugated or conjugated to a selection of fluorochromes. Intra-Cell concentrate for cell permeabilization is being released at this time as well.